| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/02/2012 | US20120027753 MicroRNAs in Never-Smokers and Related Materials and Methods |
| 02/02/2012 | US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 02/02/2012 | US20120027750 Method and compositions for cancer prognosis |
| 02/02/2012 | US20120027749 Method |
| 02/02/2012 | US20120027744 Modified heparinase iii and methods of sequencing therewith |
| 02/02/2012 | US20120027742 Methods for treating adult respiratory distress syndrome |
| 02/02/2012 | US20120027739 T cell receptors |
| 02/02/2012 | US20120027727 Targeted nanoparticles for cancer and other disorders |
| 02/02/2012 | US20120027725 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer |
| 02/02/2012 | US20120027720 Peptide conjugates |
| 02/02/2012 | US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method |
| 02/02/2012 | US20120027684 Cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 02/02/2012 | US20120027682 Pyrazine Derivatives for Optical Imaging and Therapy |
| 02/02/2012 | US20120027680 Oxime conjugates and methods for their formation and use |
| 02/02/2012 | US20120027676 Modified sodium iodide symporter proteins and uses thereof |
| 02/02/2012 | US20120027675 Targeting pulmonary epithelium using adrp |
| 02/02/2012 | US20120027674 Il-18 receptor as a novel target of regulatory t cells in cancer |
| 02/02/2012 | CA2807199A1 Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics |
| 02/02/2012 | CA2806820A1 N-methylformamide solvate of dasatinib |
| 02/02/2012 | CA2806665A1 Anticancer derivatives, preparation thereof and therapeutic use thereof |
| 02/02/2012 | CA2806610A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 02/02/2012 | CA2806332A1 Quinoline derivatives and melk inhibitors containing the same |
| 02/02/2012 | CA2806094A1 Composition and method for photodynamic disinfection |
| 02/02/2012 | CA2806006A1 Vinylogous chalcone derivatives and their medical use |
| 02/02/2012 | CA2805494A1 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor |
| 02/02/2012 | CA2805445A1 Pharmaceutical and/or dietary compositions based on short chain fatty acids |
| 02/02/2012 | CA2804709A1 Immunogenic anti-inflammatory compositions |
| 02/02/2012 | CA2803387A1 Cyclic amine azaheterocyclic carboxamides |
| 02/02/2012 | CA2729798A1 Novel anti-vegf biologics |
| 02/01/2012 | EP2412808A1 Lh-type bispecific antibody |
| 02/01/2012 | EP2412805A1 Gene involved in immortalization of human cancer cell and use thereof |
| 02/01/2012 | EP2412758A1 Polyion complex comprising hydrophobized polyamino acid and use of same |
| 02/01/2012 | EP2412728A2 Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor |
| 02/01/2012 | EP2412707A2 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 02/01/2012 | EP2412706A2 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
| 02/01/2012 | EP2412705A1 Novel therapeutic agent for cognitive impairment |
| 02/01/2012 | EP2412377A1 Burdock fruit extract containing arctigenin at high content and process for producing same |
| 02/01/2012 | EP2411529A2 N-linked glycan biosynthesis modulators |
| 02/01/2012 | EP2411506A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
| 02/01/2012 | EP2411415A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 02/01/2012 | EP2411411A1 Novel anti-alpha5beta1 antibodies and uses thereof |
| 02/01/2012 | EP2411391A1 Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| 02/01/2012 | EP2411368A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs |
| 02/01/2012 | EP2411367A1 Anticancer derivatives, preparation thereof, and therapeutic use thereof |
| 02/01/2012 | EP2411366A1 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors |
| 02/01/2012 | EP2411364A1 Anticancer compounds, preparation thereof, and therapeutic use thereof |
| 02/01/2012 | EP2411040A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents |
| 02/01/2012 | EP2411031A2 Methods and compositions for the treatment of cancer |
| 02/01/2012 | EP2411012A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 02/01/2012 | EP2411011A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 02/01/2012 | EP2411010A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 02/01/2012 | EP2411007A2 Modulating ires-mediated translation |
| 02/01/2012 | EP2331546B1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
| 02/01/2012 | EP2190426B1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 02/01/2012 | EP2188297B1 Pyrrolo [2,1-c][1, 4] benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent |
| 02/01/2012 | EP2176296B1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 02/01/2012 | EP2132174B1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors |
| 02/01/2012 | EP2094260B1 Treatment of lung cancer |
| 02/01/2012 | EP2078016B1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/01/2012 | EP2077855B1 Therapeutic use of gba2 |
| 02/01/2012 | EP2066319B1 Benzotriazole kinase modulators |
| 02/01/2012 | EP2061494B1 Regulation of expression of p140cap protein in tumors |
| 02/01/2012 | EP1909811B1 Hox peptides as pbx modulators for the treatment of cancer |
| 02/01/2012 | EP1848719B1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 02/01/2012 | EP1511725B1 24-sulfoximine vitamin d3 compounds |
| 02/01/2012 | EP1286989B1 Prodrug of an ICE inhibitor |
| 02/01/2012 | CN1931285B 一种中药组合物及其制备方法 Chinese medicinal composition and its preparation method |
| 02/01/2012 | CN1879761B 一种调节机体免疫力、抗突变保健品及其生产方法 A regulator of immunity, anti-mutagenic health products and production methods |
| 02/01/2012 | CN1846694B 取代芳香基双胍类化合物及含它们的药物组合物在制备抗恶性肿瘤药物方面的应用 Biguanide compounds and substituted aromatic group-containing pharmaceutical compositions thereof for the manufacture of anti-cancer drugs |
| 02/01/2012 | CN102341411A Anti-lymphotoxin antibodies |
| 02/01/2012 | CN102341402A Thienopyridines as pharmacologically active agents |
| 02/01/2012 | CN102341400A Pyrrolopyrimidines used as kinase inhibitors |
| 02/01/2012 | CN102341398A Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| 02/01/2012 | CN102341394A Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 02/01/2012 | CN102341393A Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
| 02/01/2012 | CN102341386A Pyridine derivative |
| 02/01/2012 | CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase |
| 02/01/2012 | CN102341372A Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/01/2012 | CN102341118A Compositions and methods for visualizing and eliminating cancer stem cells |
| 02/01/2012 | CN102341112A Method and means for producing tissues and tissues obtained |
| 02/01/2012 | CN102341110A Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| 02/01/2012 | CN102341107A Combination therapies for neoplastic disorders |
| 02/01/2012 | CN102341102A Use of pyrimidylaminobenzamide derivatives for treatment of disorders mediated by leucine zipper- and sterile alpha motif-containing kinase (zak) |
| 02/01/2012 | CN102341008A Covalent milk protein/isothiocyanate complexes |
| 02/01/2012 | CN102337332A Gene and application of protein encoded by gene to preparation of medicine for diagnosing and treating breast cancer |
| 02/01/2012 | CN102337298A Immune nano-carrier for conveying siRNA (small interfering Ribonucleic Acid) and preparation method and application thereof |
| 02/01/2012 | CN102337297A Mbr-FPGS (folylpolyglutamate synthetase) efficient expression vector and construction method and application thereof |
| 02/01/2012 | CN102337268A Human CTRP4 gene, its coding protein and their application |
| 02/01/2012 | CN102337244A Dendritic cell loaded with antigen of tumor cell subjected to chemotherapy drug tolerance screening, its preparation method and application |
| 02/01/2012 | CN102336904A Multivalent polyglycol (PEG) modifier for camptothecin and derivatives thereof and application of multivalent PEG modifier |
| 02/01/2012 | CN102336835A Fusion protein of interleukin-3 derived fragment and purpose thereof |
| 02/01/2012 | CN102336833A CHD1L-TCTP binding blocking agent as well as medical combination with same and application thereof |
| 02/01/2012 | CN102336825A Balsam pear protein as well as preparation method and application of balsam pear protein in preparing antitumor medicament |
| 02/01/2012 | CN102336822A Truncate human papilloma virus (HPV) 58 type L1 protein |
| 02/01/2012 | CN102336821A New Melan-A epitope peptide and application thereof in preventing and/or treating tumours |
| 02/01/2012 | CN102336812A Polypeptide possessing angiogenesis inhibitory activity |
| 02/01/2012 | CN102336811A Novel small peptide capable of inhibiting new vessels and application thereof |
| 02/01/2012 | CN102336802A Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method |
| 02/01/2012 | CN102336768A N'-arylmethylene-2-(4-oxothiophene[2,3-d]pyrimidin-3-yl)acetyl hydrazone compounds, and preparation method and application thereof |
| 02/01/2012 | CN102336764A Spin-labeling rotenone oxime ester, its preparation method and application |